Arbor Surgical Technologies, Inc. is a privately held company based in Irvine and Portola Valley, CA (USA) that focuses on developing innovative cardiovascular medical devices for the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and heart valve designer Ernie Lane, the company is dedicated to creating multiple technologies with significant clinical benefits for patients globally. Arbor's current focus is on a family of tissue heart valve products aimed at improving performance over existing valves, along with compatible implantation tools to simplify and expedite valve replacement surgery.
The company's slogan underscores its commitment to advancing patient care and enhancing surgical efficiency. Arbor has garnered significant attention from investors, securing a $20.00M Series C investment on 30 January 2008. The impressive list of investors includes Baird Capital, Kaiser Permanente Ventures, Alloy Ventures, Delphi Ventures, Sage Venture Partners, Three Arch Partners, Johnson & Johnson Development Corporation, Fisk Ventures, Sapient Capital Management, and Medtronic.
Arbor Surgical Technologies operates in the Health Care, Manufacturing, and Medical Devices industries, positioning itself at the intersection of cutting-edge medical technology and patient-centered care.
